Home › Funds › PSP Research LLC › SNDX

PSP Research LLC position in SNDX

SYNDAX PHARMACEUTICALS INC · Health Care

PSP Research LLC reported holding 12,000 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$226K, representing 0.15% of its reported portfolio and ranking #30 among its reported holdings. PSP Research LLC has disclosed SNDX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)12.00K sh
Reported value held$225.60K
Portfolio Weight0.15%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's SNDX position evolved

PSP Research LLC first disclosed a stake in SNDX in Q4 2025 at 24,716 shares (US$519K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$226K — a reduction of -8,000 shares quarter over quarter.. Notable position changes include a 40% trim in Q3 2026 (shares fell 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 24.72K $519.28K New
Q1 2026 20.00K $467.20K Reduce
Q2 2026 20.00K $437.20K Hold
Q3 2026 12.00K $225.60K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SNDX and 13F data

SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SNDX

All SNDX fund holders →

FAQ

How long has PSP Research LLC held SNDX?

PSP Research LLC has disclosed SNDX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in SNDX?

As of Q3 2026, PSP Research LLC holds 12.00K shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $225.60K, representing 0.15% of its reported portfolio and ranking #30.

Has PSP Research LLC been buying or selling SNDX?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in SNDX.

Which other funds hold SNDX?

Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.